Skip to main content
Article thumbnail
Location of Repository

Bacteria-Induced Uroplakin Signaling Mediates Bladder Response to Infection

By Praveen Thumbikat, Ruth E. Berry, Ge Zhou, Benjamin K. Billips, Ryan E. Yaggie, Tetiana Zaichuk, Tung-Tien Sun, Anthony J. Schaeffer and David J. Klumpp


Urinary tract infections are the second most common infectious disease in humans and are predominantly caused by uropathogenic E. coli (UPEC). A majority of UPEC isolates express the type 1 pilus adhesin, FimH, and cell culture and murine studies demonstrate that FimH is involved in invasion and apoptosis of urothelial cells. FimH initiates bladder pathology by binding to the uroplakin receptor complex, but the subsequent events mediating pathogenesis have not been fully characterized. We report a hitherto undiscovered signaling role for the UPIIIa protein, the only major uroplakin with a potential cytoplasmic signaling domain, in bacterial invasion and apoptosis. In response to FimH adhesin binding, the UPIIIa cytoplasmic tail undergoes phosphorylation on a specific threonine residue by casein kinase II, followed by an elevation of intracellular calcium. Pharmacological inhibition of these signaling events abrogates bacterial invasion and urothelial apoptosis in vitro and in vivo. Our studies suggest that bacteria-induced UPIIIa signaling is a critical mediator of bladder responses to insult by uropathogenic E. coli

Topics: Research Article
Publisher: Public Library of Science
OAI identifier:
Provided by: PubMed Central

Suggested articles


  1. (1985). A new generation of Ca2+ indicators with greatly improved fluorescence properties.
  2. (2007). A novel TLR4-mediated signaling pathway leading to IL-6 responses in human bladder epithelial cells. PLoS Pathog 3:
  3. (2000). Ablation of uroplakin III gene results in small urothelial plaques, urothelial leakage, and vesicoureteral reflux.
  4. (1980). Adhesive properties of enterobacteriaceae.
  5. (2006). Altered phenotype of cultured urothelial and other stratified epithelial cells: implications for wound healing.
  6. (2006). Antigenspecific responses accelerate bacterial clearance in the bladder.
  7. (2007). Apical Epidermal Growth Factor Receptor Signaling: Regulation of Stretch-dependent Exocytosis in Bladder Umbrella Cells.
  8. (2007). Assays of protein kinases using exogenous substrates.
  9. (2005). Assembly of urothelial plaques: tetraspanin function in membrane protein trafficking.
  10. (1990). Assessing the differentiation state of cultured bovine urothelial cells: elevated synthesis of stratification-related K5 and K6 keratins and persistent expression of uroplakin I.
  11. (2002). Assessment of virulence of uropathogenic Escherichia coli type 1 fimbrial mutants in which the invertible element is phase-locked on or off.
  12. (2002). Bacterial adhesion to target cells enhanced by shear force.
  13. (2001). Bacterial invasion augments epithelial cytokine responses to Escherichia coli through a lipopolysaccharide-dependent mechanism.
  14. (2000). Bad bugs and beleaguered bladders: interplay between uropathogenic Escherichia coli and innate host defenses.
  15. (2003). Calcium signalling: dynamics, homeostasis and remodelling.
  16. (1991). Chaperone-assisted assembly and molecular architecture of adhesive pili.
  17. (2005). Characterization of Mannheimia (Pasteurella) haemolytica leukotoxin interaction with bovine alveolar macrophage beta2 integrins.
  18. (2007). Characterization of Xenopus egg membrane microdomains containing uroplakin Ib/III complex: roles of their molecular interactions for subcellular localization and signal transduction.
  19. (2008). Clathrin, AP-2, and the NPXY-binding subset of alternate endocytic adaptors facilitate FimHmediated bacterial invasion of host cells.
  20. (2007). Cyclic AMPregulated exocytosis of Escherichia coli from infected bladder epithelial cells. Nature Med advance online publication 08
  21. (2005). De novo Uroplakin IIIa heterozygous mutations cause human renal adysplasia leading to severe kidney failure.
  22. (2009). Differentiationinduced uroplakin III expression promotes urothelial cell death in response to uropathogenic E.
  23. (2006). Distinct glycan structures of uroplakins Ia and Ib: structural basis for the selective binding of FimH adhesin to uroplakin Ia.
  24. (1995). Effect of vaginal fluid on adherence of type 1 piliated Escherichia coli to epithelial cells.
  25. (2003). Epidemiology of urinary tract infections: incidence, morbidity, and economic costs.
  26. (2001). Establishment of a persistent Escherichia coli reservoir during the acute phase of a bladder infection.
  27. (1996). FACS-optimized mutants of the green fluorescent protein (GFP).
  28. (1996). In vitro binding of type 1-fimbriated Escherichia coli to uroplakins Ia and Ib: relation to urinary tract infections.
  29. (1998). Induction and evasion of host defenses by type 1-piliated uropathogenic Escherichia coli.
  30. (2005). Induction of the urothelial differentiation program in the absence of stromal cues.
  31. (2007). Integrin-mediated host cell invasion by type 1-piliated uropathogenic Escherichia coli. PLoS Pathog 3:
  32. (1990). Large scale purification and immunolocalization of bovine uroplakins I, II, and III. Molecular markers of urothelial differentiation.
  33. (1994). Mammalian uroplakins. A group of highly conserved urothelial differentiation-related membrane proteins.
  34. (2006). Mechanisms of uropathogenic Escherichia coli persistence and eradication from the urinary tract.
  35. (1993). Molecular cloning of a 47 kDa tissue-specific and differentiation-dependent urothelial cell surface glycoprotein.
  36. (2005). Molecular identification and characterization of Xenopus egg uroplakin III, an egg raft-associated transmembrane protein that is tyrosine-phosphorylated upon fertilization.
  37. (2005). p63 regulates commitment to the prostate cell lineage.
  38. (1999). Pilus chaperone FimC-adhesin FimH interactions mapped by TROSY-NMR.
  39. (1994). Precursor sequence, processing, and urothelium-specific expression of a major 15-kDa protein subunit of asymmetric unit membrane.
  40. (1997). Prevention of mucosal Escherichia coli infection by FimH-adhesin-based systemic vaccination.
  41. (1986). Regulation of production of type 1 pili among urinary tract isolates of Escherichia coli.
  42. (1987). Relationship of type 1 pilus expression in Escherichia coli to ascending urinary tract infections in mice.
  43. (2002). Requirement of Rho-family GTPases in the invasion of Type 1-piliated uropathogenic Escherichia coli.
  44. (1985). Role of type 1 pili and effects of phase variation on lower urinary tract infections produced by Escherichia coli.
  45. (1995). Selective interactions of UPIa and UPIb, two members of the transmembrane 4 superfamily, with distinct single transmembrane-domained proteins in differentiated urothelial cells.
  46. (1993). Signal transduction in the mammalian cell during bacterial attachment and entry.
  47. (2002). Specific heterodimer formation is a prerequisite for uroplakins to exit from the endoplasmic reticulum.
  48. (2005). Tetraspanin functions and associated microdomains.
  49. (2007). TLR4-initiated and cAMP-mediated abrogation of bacterial invasion of the bladder.
  50. (2000). Type 1 pilus-mediated bacterial invasion of bladder epithelial cells.
  51. (1995). Uehling DT
  52. (2006). Uropathogenic Escherichia coli induces extrinsic and intrinsic cascades to initiate urothelial apoptosis.
  53. (2001). Uropathogenic Escherichia coli potentiates type 1 pilus-induced apoptosis by suppressing NF-kappaB.
  54. (2001). Uroplakin Ia is the urothelial receptor for uropathogenic Escherichia coli: evidence from in vitro FimH binding.
  55. (2005). Uroplakin III, a novel Src substrate in Xenopus egg rafts, is a target for sperm protease essential for fertilization.
  56. (2002). Uroplakin IIIb, a urothelial differentiation marker, dimerizes with uroplakin Ib as an early step of urothelial plaque assembly.
  57. (1994). Uroplakins Ia and Ib, two major differentiation products of bladder epithelium, belong to a family of four transmembrane domain (4TM) proteins.
  58. (2006). Urothelial lesion formation is mediated by TNFR1 during neurogenic cystitis.

To submit an update or takedown request for this paper, please submit an Update/Correction/Removal Request.